Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The rising demand for synthesized oligos in molecular diagnostics and therapeutics, increasing R&D expenditure by pharmaceutical and biotechnology companies, rising venture capital investments, and the increasing demand for synthetic genes are the major factors driving the growth of oligonucleotide synthesis market. Therapeutic Application to Dominate the Global Oligonucleotide Synthesis Market: Therapeutic Application: 1. DNA and Antisense Oligonucleotide-based Therapies 2. RNAi Oligonucleotide-based Therapies 3. CpG Oligonucleotide-based Therapies The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA and antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period. This can primarily be attributed to the investments made by companies to explore the therapeutic applications of oligos. Also, from 2016 to 2018, more tha

The growth of 3d cell culture market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the forecast period. 3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region. The global 3D cell culture market size is projected to reach USD 1,846 million in 2024 from USD 892 million in 2019, at a CAGR of 15.7%. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847 The Global 3D Cell Culture Market is Segmented on: 1. Product 2. Application 3.

The Global Autoimmune Disease Diagnosis Market Size Is Expected To Grow From Usd 6.3 Billion By 2025 From Usd 4.1 Billion In 2020, At A Cagr Of 8.9%. This Industry Is Experiencing Significant Growth Due To The High Incidence Of Autoimmune Diseases, Increasing Awareness About Autoimmune Diseases, And The Growth In Research On Autoimmune Diseases. Autoimmune Disease Diagnosis Market By Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (Ra, Sle, Thyroiditis, Scleroderma), End User (Hospitals, Clinical Labs). Download Pdf Brochure: Https://Www.Marketsandmarkets.Com/Pdfdownloadnew.Asp?Id=174826519 Autoimmune Disease Diagnosis Market by Product: 1. Consumables & Assay Kits 2. Instruments Autoimmune Disease Diagnosis Market by Disease: 1. Rheumatoid Arthritis 2. Systemic Lupus Erythematosus 3. Sjogren’s Syndrome 4. Thyroiditis 5. Scleroderma Autoimmune Disease Diagnosis Industry by End User: 1. Cl

A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global pain management devices market. Pain management device are used to manage chronic and acute pain in patients suffering from various conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore the ability of patients to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. The global pain management devices market is valued at an estimated USD 4.64 Billion in 2021 and is projected to grow at a CAGR of 8.5%.

Factors such as process miniaturization, high demand for lab automation equipment in drug discovery and clinical diagnostics, higher reproducibility and accuracy, and large workforce demand and supply gap are likely to drive the growth of lab automation market. In addition, lab automation offers enhanced productivity and reduced costs, better personnel safety, and small volumes of samples and reagents. Lab automation is defined as the use of technology to streamline or substitute manual manipulation of equipment and processes. While an academic research lab may prefer to use only some instruments in order to increase productivity and reduce the time spent on a tedious task, a drug discovery unit in a pharmaceutical company will perhaps need to automate all of its research phases. The global lab automation market is expected to reach USD 5.20 Billion by 2022 from USD 4.06 Billion in 2017, at a CAGR of 5.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadN

The growth of 3d cell culture market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the forecast period. 3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region. The global 3D cell culture market size is projected to reach USD 1,846 million in 2024 from USD 892 million in 2019, at a CAGR of 15.7%. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847 The Global 3D Cell Culture Market is Segmented on: 1. Product 2. Application 3.

The major factors driving the growth of diagnostic imaging services market include the rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases and growing awareness about early disease detection and the widening scope of clinical applications. Diagnostic Imaging Services Market by Procedure (MRI, Ultrasound, X-RAY, CT, Nuclear Imaging (SPECT, PET), Mammography), Application (OB/Gyn, Orthopedics, Oncology, Vascular, Neurology), End User (Hospitals, Imaging Centers) The diagnostic imaging services market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17157849 In 2018, the x-ray segment accounted for the largest share of the diagnostic imaging services market. On the basis of modality, the diagnostic imaging services market is segmented into magnetic resonance imaging (MRI), ultrasound, compute

Growth in the mass spectrometry market is primarily driven by factors such as government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and technological advancements in mass spectrometers. The mass spectrometry market is expected to grow from USD 4.6 billion in 2019 to USD 6.3 billion by 2024, at a CAGR of 6.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437 Pharmaceutical & Biotechnology applications held the largest share of the mass spectrometry market: Mass spectrometry is widely used for accurate analysis of small as well as large molecules in pharmaceuticals, forensic & clinical research, and other areas. The mass spectrometry applications market is segmented into pharmaceutical & biotechnology applications, envi

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816 RNA sequencing platforms & consumables segment accounted for the largest share of the NGS-based RNA-sequencing market, by product & service, in 2018 Based on products & service, the market is segmented into sample preparation, RNA sequencing platforms & consumables, RNA sequencing services, and data analysis, storage & management. In 2018, the RNA sequencing platforms & consumables segment accounted for the largest share of the NGS based RNA sequencing market. This can

Radiotherapy Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy, and the growing use of  particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. The radiotherapy market is projected to grow from an estimated USD 5.6 billion in 2018 to USD 6.8 billion by 2023, at a CAGR of 4.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567 By type, the external beam radiotherapy segment is expected to grow at the highest rate during the forecast period Based on type, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiothera

Factors such increased product availability of smoke evacuation systems, rising patient preference for minimally invasive surgeries, expansion in the target patient population, and wider acceptance and availability of relevant operating room protocols and guidelines for smoke evacuation systems are the major factors driving the growth of the global smoke evacuation systems market. Smoke Evacuation System Market by Product (Smoke Evacuator (Portable & Stationary), Filter, Pencil, Accessories), Application (General Surgery, Laparoscopic, Orthopedic, Aesthetic), End-User (Hospitals, ASC, Surgical Centers). The surgical smoke evacuation system market is estimated to grow at a CAGR of 6.6% to reach USD 223 million by 2024 from USD 162 million in 2019. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149736406 Global Smoke Evacuation System Market is Segmented on: 1. Product 2. Application 3. End User 4. Region Application of Smoke Evacu

Growth in the mass spectrometry market is primarily driven by factors such as government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and technological advancements in mass spectrometers. Mass Spectrometry Market by Platform (Hybrid Mass Spectrometry (Triple Quadrupole, QTOF, FTMS), Single Mass Spectrometry (Quadrupole, TOF, Ion Trap)), Application (Pharma & Biotech, Environmental & Food Testing). The mass spectrometry market is expected to grow from USD 4.6 billion in 2019 to USD 6.3 billion by 2024, at a CAGR of 6.7% . Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437 Applications of Mass Spectrometry: 1. Pharmaceuticals Companies 2. Biotechnology Companies 3. Environmental 4. Food Testing Mass spectrometry is widely

According to the recent report “ Plasma Therapy Market  by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedic, Dermatology, Cardiac Muscle Injury), End User, Region - Global Forecast to 2021". The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0%. Browse in-depth TOC on “ Plasma Therapy Market ” 141 – Tables 98 – Figures 210 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186196333 Factors driving the growth of the plasma therapy market include rising incidences of trauma and increasing healthcare expenditure worldwide. The pure PRP segment is estimated to account for the largest share of the global plasma therapy market in 2016. This segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of the pure PRP segment can be attributed

The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic. At MarketsandMarkets™ , analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Live Cell Encapsulation Market. We are working diligently to help companies take rapid decisions by studying: 1. The impact of COVID-19 on the Live Cell Encapsulation Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market. 2. The rapid shifts in the strategies of the Top 50 companies in the Live Cell Encapsulation Market 3. The shifting short-term priorities of the top 50 companies’ clients and their client's clients You can request an in-depth analysis detailing the impact of COVID-19 on the Live Cell Encapsulation Market: https://www.ma

Healthcare Business Intelligence (BI) Market by Component (Platform, Software, Service), Function (OLAP, Performance Management), Application (RCM, Inventory, Strategy Analysis), Deployment Model (Cloud, Hybrid) & End User (Payer, Hospital) - Forecast to 2023. The healthcare business intelligence market is expected to reach USD 8.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 15.3% . Request Sample Report Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=252368925 Global Healthcare Business Intelligence Market is Segmented on: 1. Component 2. Application 3. End User 4. Region Factors such as the implementation of government initiatives to increase EHR adoption, growing adoption of data-driven decision-making, growing pressure to curb healthcare spending and improve patient outcomes, big data in healthcare, and the increasing number of patient registries are expected to drive the growth of the healthcare business intelligence (BI) market.

The major factors driving the growth of diagnostic imaging services market include the rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases and growing awareness about early disease detection and the widening scope of clinical applications. On the other hand, factors such as the high cost of diagnostic imaging systems and the low reimbursement structure for outpatient imaging facilities are likely to restrain the growth of the market to a certain extent in the coming years. The diagnostic imaging services market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1% from 2019 to 2024. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17157849 Asia Pacific is Land of Opportunities for Diagnostic Imaging Services Market: Asia Pacific market is estimated to grow at the highest CAGR during the forecast period primarily due to the improving healthcare in

The growth of  microplate system market  is mainly driven by growing prevalence of diseases, increasing focus on minituarisation of processes, technological advancements, and increasing R&D expenditure in the pharmaceutical industry. The global  microplate system market  is expected to reach USD 996.9 Million by 2022 from USD 820.3 Million in 2017 at a CAGR of 4.0%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37081572 Biotechnology and Pharmaceuticals Companies are Fastest Growing End User Segment: Microplate system market is segmented into biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, and research and academic institutes. The biotechnology and pharmaceutical companies segment is expected to be the fastest growing during the forecast period. This growth is attributed to the increasing government support in the form of funding for biotech and pharma research. Drug Discovery Segment: The drug discov